| Financial Year |
March 31 2023 |
| Monetary Funds |
966,872,492.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,055,336.17 |
| Accounts Receivable |
533,205,200.12 |
| Advances to Suppliers |
188,717,312.07 |
| Other Receivables |
63,355,139.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
900,000.00 |
| Inventories |
1,400,847,283.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
104,460,000.00 |
| Other Current Assets |
103,533,394.34 |
| Total Current Assets |
5,588,448,308.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
350,911,404.67 |
| Long-term Equity Investment |
138,039,027.53 |
| Investment Properties |
438,289,714.71 |
| Fixed Assetes |
812,370,913.67 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
54,615,685.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
23,909,199.85 |
| Deferred Income Tax Assets |
31,732,078.17 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,235,095,605.73 |
| Total Assets |
7,823,543,914.40 |
| Short-Term Loans |
250,000,000.00 |
| Trading Financial liabilities |
559,895.47 |
| Notes Payable |
12,821,491.50 |
| Accounts Payable |
1,352,705,027.16 |
| Accounts Received In Advance |
195,419.05 |
| Employee Compensation Payable |
66,001,209.26 |
| Taxes Payable |
12,169,009.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
206,307,392.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,631,355.59 |
| Other Current Liabilities |
13,559,137.18 |
| Sub-Total of Current Liabilities |
2,861,883,721.64 |
| Long-term Loans |
497,757,120.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
21,441,509.17 |
| Deferred Income Tax Liabilities |
9,253,009.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
596,482,942.56 |
| Total Liabilities |
3,458,366,664.20 |
| Paid-In Capital(Or Share Stock) |
736,249,883.00 |
| Capital Surplus |
2,444,017,760.42 |
| Surplus Reserve |
242,453,429.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
585,026,199.80 |
| Minority Stockholder's Interest |
326,974,657.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,038,202,593.09 |
| Owner's Equity（Stockholder's Equity） |
4,365,177,250.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,823,543,914.40 |
